What Is Microdosing GLP-1? Everything You Need to Know

Quick Answer

Microdosing GLP-1 means using semaglutide or tirzepatide at lower doses than standard weight loss protocols — typically 0.25-0.5mg weekly of semaglutide — to achieve metabolic optimization, improved body composition, and enhanced performance without the aggressive appetite suppression associated with higher doses. It's designed for people who don't need to lose significant weight but want the metabolic benefits of GLP-1 receptor activation.

What Is GLP-1?

GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces in your gut after eating. It signals fullness to your brain, slows gastric emptying, helps regulate blood sugar, and improves insulin sensitivity. Medications like semaglutide and tirzepatide are synthetic versions of GLP-1 that last much longer in your body than the natural hormone — enabling once-weekly dosing.

At standard doses (up to 2.4mg semaglutide weekly), these medications produce dramatic appetite suppression and significant weight loss — 15-21% of body weight in clinical trials. That's the protocol designed for obesity treatment.

Microdosing takes a fundamentally different approach.

What Makes Microdosing Different

The key difference is intent and dosing. Standard GLP-1 therapy starts at 0.25mg and titrates up to 2.4mg, with the goal of maximizing appetite suppression and weight loss. Microdosing stays at the low end — 0.25-0.5mg — with no intention of escalating.

At these lower doses, you get the metabolic benefits of GLP-1 activation without the drawbacks that come with aggressive appetite suppression:

Insulin sensitivity improves. Even low doses enhance how your cells respond to insulin, improving nutrient partitioning — more of what you eat goes to muscle, less to fat. For anyone who trains, this is arguably the most valuable effect.

Inflammation decreases. GLP-1 receptors exist throughout your cardiovascular system, liver, and adipose tissue. Activating them reduces systemic inflammatory markers (CRP, IL-6, TNF-alpha), which benefits recovery, joint health, and long-term disease risk.

Blood glucose stabilizes. Even in non-diabetic individuals, microdosed GLP-1 smooths out the glucose spikes and crashes that affect energy and cognitive performance throughout the day.

Appetite is modulated, not eliminated. You eat slightly less, not dramatically less. Hitting protein targets remains feasible. Training performance isn't compromised by a crushing caloric deficit.

Who Is Microdosing GLP-1 For?

The typical microdosing patient looks nothing like the typical weight loss patient. These are people who:

• Already train regularly and eat reasonably well
• Want to lose 10-15 pounds of stubborn fat without sacrificing muscle
• Have a BMI of 20-28 (i.e., not obese, possibly not even overweight by standard metrics)
• Are interested in metabolic optimization, body recomposition, or performance enhancement
• Want the cardiovascular and metabolic benefits of GLP-1 independent of weight loss
• Are in their 30s-40s and noticing early metabolic decline despite healthy habits

The qualification threshold is essentially anyone with a BMI over 20 — which dramatically expands who can benefit from GLP-1 therapy beyond the traditional obesity-focused patient.

How It Works at Marrow

At Marrow, microdosing GLP-1 is offered through our [Performance protocol](/treatments/performance), starting at $179/month. Here's how it works:

1. Complete your intake — A 5-minute questionnaire about your health, training, and goals.
2. Physician review — Your physician evaluates whether microdosing is appropriate for you and discusses the protocol.
3. Start low, stay low — You begin at 0.25mg semaglutide (or equivalent tirzepatide) weekly. Unlike standard protocols, the goal isn't to titrate up aggressively.
4. Monitor and adjust — Bloodwork at baseline and 12 weeks tracks metabolic improvements. Dosing is adjusted based on response.

What Results to Expect

Here's a realistic timeline:

• Weeks 1-2: Subtle appetite modulation, more stable energy, possibly mild GI adjustment
• Weeks 3-6: Improved fasting glucose, better workout recovery, improved sleep
• Months 2-3: Visible body recomposition — less body fat with maintained or improved strength
• Months 3-6: Optimized metabolic markers, sustained performance improvements

The experience is fundamentally different from high-dose GLP-1. There's no nausea, no food aversion. It feels like your metabolism has been quietly upgraded.

Microdosing GLP-1 vs Standard GLP-1

| Feature | Standard GLP-1 | Microdose GLP-1 | |---------|---------------|-----------------| | Dose range | 0.25-2.4mg semaglutide | 0.25-0.5mg semaglutide | | Primary goal | Weight loss (15-21%) | Metabolic optimization | | Appetite effect | Dramatic suppression | Mild modulation | | Muscle impact | Risk of loss without protocol | Minimal to none | | Nausea | Common during titration | Rare | | Who it's for | BMI 27+ | BMI 20+ | | Marrow price | From $249/mo | From $179/mo |

The Stack: GLP-1 + TRT

For patients who qualify, combining microdosed GLP-1 with [testosterone replacement therapy](/treatments/testosterone) is one of the most effective body recomposition protocols available. GLP-1 optimizes metabolic function and nutrient partitioning. Testosterone directly stimulates muscle protein synthesis and recovery. Together, they create conditions where your body preferentially burns fat while building lean tissue.

Is It Safe?

Microdosing GLP-1 carries even fewer risks than standard dosing because the doses are lower. Side effects (nausea, GI issues) are rare at these levels. Your Marrow physician monitors your bloodwork and adjusts the protocol based on your response.

Frequently Asked Questions

Can I microdose GLP-1 if I'm not overweight? Yes. The metabolic benefits — improved insulin sensitivity, reduced inflammation, cardiovascular protection — are valuable regardless of current body weight. A BMI over 20 is generally sufficient.

Will microdosing help me lose weight? Some modest weight loss (5-10 lbs) is common, but the primary effect is body recomposition — less fat, same or more muscle — rather than dramatic scale changes.

How long should I stay on it? Some patients use microdosed GLP-1 cyclically (3-6 months on, then off). Others maintain a low dose indefinitely for metabolic health. Your physician will help you decide based on your goals and labs.

Can I combine it with other medications? Yes. Microdosed GLP-1 is commonly combined with TRT, NAD+ protocols, and other Marrow treatments. Your physician coordinates all protocols.

Start your [performance protocol at Marrow](/treatments/performance) — microdosing GLP-1 from $179/mo, with physician oversight and all supplies included.